This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: The Innovative Contributions of Ya Ling Liang
Introduction
Ya Ling Liang is a prominent inventor based in Guiyang, China. She has made significant strides in the field of biotechnology, particularly in the detection of circulating tumor DNA (ctDNA). Her work is crucial for advancing cancer treatment and improving patient outcomes.
Latest Patents
Ya Ling Liang holds a patent for a "Kit for detecting ctDNA and expression of drug-resistant genes related to applicability of tumor chemotherapeutic drugs." This innovative kit allows for the determination of ctDNA concentration through a method that involves dissolving extracted ctDNA in Tris-HCl buffer with a pH greater than 7.0. The process includes adding 2,7-bis(1-methyl-4-vinylpyridine)-9-ethylcarbazole iodised salt as a molecular probe. The concentration of ctDNA in the solution is calculated by measuring the fluorescence intensity, demonstrating extremely high sensitivity in determining ctDNA concentrations ranging from 0 µg/ml to 50 µg/ml.
Career Highlights
Throughout her career, Ya Ling Liang has focused on developing innovative solutions that address critical challenges in cancer treatment. Her dedication to research and development has led to advancements that are not only scientifically significant but also have practical applications in clinical settings.
Collaborations
Ya Ling Liang has collaborated with notable colleagues, including Hai Zhuang and Rui Gao. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Ya Ling Liang's contributions to the field of biotechnology, particularly in the detection of ctDNA, highlight her innovative spirit and commitment to improving cancer treatment. Her work continues to pave the way for advancements in medical technology and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile